BNET Pharma

Today’s Top Pharma News and Analysis

• Widely Used Cancer Drug Causes Potentially Deadly Holes in GI Tract

  NaturalNews - 16 hours 25 minutes ago

  (NaturalNews) Bevacizumab is the generic name for the widely used Genetech cancer drug marketed as Avastin. It inhibits tumor growth by blocking angiogenesis, the formation of new blood vessels. But according to an article just published in the June edition of The Lancet Oncology, cancer patients treated with Avastin in...

  • Pfizer abandons Ph III Sutent colon cancer study | In-Pharma Technologist
  • Repros drops top dose for late-stage study | FierceMarkets

• Border Agents to Dump Agent Orange-Like Chemical to Kill All Plant Life Among U.S.-Mexico Border

  NaturalNews - 16 hours 25 minutes ago

  (NaturalNews) The Border Patrol has temporarily postponed -- but refused to cancel -- plans to use helicopters to spray herbicide along the banks of the Rio Grande between the cities of Laredo, Texas and Nuevo Laredo, Mexico, in order to kill a fast-growing river cane that provides cover for undocumented...

  • Mexico's woes | BBC
  • Tough Times For Mexican Immigrants | Forbes
  • The WonkLine: July 2, 2009 | Wonk Room

• J&J Buys Ã?Â?Ã?£610 Million Elan Stake

  Reuters UK - 16 hours 38 minutes ago

  By Toni ClarkeBOSTON (Reuters UK) - Johnson & Johnson JNJ has agreed to pay $1 billion (610 million pounds) for an 18.4 percent stake in Irish drugmaker Elan Corp ELN, and will acquire a major stake in Elan's portfolio of experimental drugs to treat Alzheimer's disease.The transaction, announced on Thursday...

  • Elan did it: J&J sinks $1B into partnership$ | Fierce Pharma

• Grim Jobs Data Hammers Wall Street

  Reuters - 1 day ago

  By Ellis MnyanduNEW YORK (Reuters) - Stocks plummeted on Thursday as a worse-than-expected slide in June non-farm payrolls fanned caution about economic recovery prospects.News that U.S. employers shed nearly half a million jobs last month and that the unemployment rate jumped to 9.5 percent, the highest in nearly 26 years...

  • Grim jobs data hammers Wall Street | Reuters

• The Michael Jackson Diet That Could Have Saved Him from Death by Western Medicine

  NaturalNews - 1 day ago

  (NaturalNews) There's no question that Michael Jackson was killed by western medicine. Autopsies reveal a devastating pattern of drug injections, bone mineral loss (he suffered rib fractures when administered CPR) and hair loss. When he died, his stomach contained not food, but half-digested pharmaceuticals (http://www.s2smagazine.com/node/1206).As stated in a previous NaturalNews...

  • Learn How to Detox with a Coconut Oil Cleanse | NaturalNews
  • Michael Jackson, Entrepreneur | Forbes
  • The Sound Of One White Glove Typing | newmatilda.com
  • Vaughan Was An Inspiration | Sky News
  • Vitamin B12 Protects the Heart, Mind, Eyes and More | NaturalNews
  • Jacko Refund: Why I Don't Care | Sky News

• Common Chemo Drug Kills Women

  NaturalNews - 1 day ago

  (NaturalNews) Chemotherapy drugs used in standard cancer treatments are associated with a huge list of side effects, from hair loss and nausea to nerve pain, sexual problems and mouth sores. Now a new study from the Research on Adverse Drug Events and Reports (RADAR) pharmacovigilance program at Northwestern University Feinberg...

  • Pfizer, GSK's stop-smoking meds get warning | Fierce Pharma
  • Sutent fails in colon-cancer trial | Fierce Pharma

• Cephalon's Nuvigil Test Included "Vacation" in France

  BNET Pharma - 2 days ago

  Cephalon will ask the FDA to approve its sleep drug Nuvigil for "Eastbound" jet lag. Not Westbound. Eastbound, the company says. Turns out Cephalon flew 427 adults from the East Coast of the U.S. to France to test the drug...

• Sanofi's Lantus Cancer Scare Triggered by Doc Backed by Amylin and Lilly

  BNET Pharma - 2 days ago

  The editors of medical journal backed off from a study they published suggesting Sanofi-Aventis' diabetes drug Lantus was linked to cancer. At the same time, it emerged that the doctor who warned of an "earthquake" on Lantus has done work endorsed or sponsored by Amylin and Eli Lilly, marketers of...

• AZ wins on Iressa, could lose on Crestor

  Fierce Pharma - 2 days ago

  It's a mixed bag of AstraZeneca news today: The drugmaker finally won the Euro-OK for its oral cancer med Iressa. Thumbs up, yes? But the Crestor developments weren't so happy. One, a self-appointed patent watchdog group said it had evidence that Crestor's patent was invalid. Two, a JAMA study found...

  • AZ wins European approval for Iressa | FierceMarkets

• Lantus cancer link research flawed says Sanofi; mulls R&D restructuring

  In-Pharma Technologist - 2 days ago

  Sanofi-Aventis has moved to defend its long-acting diabetes treatment Lantus (insulin glargine) and says that recent research linking it to the development of cancer is of “poor quality.” ...

  • Amid Lantus furor, Sanofi restructures | Fierce Pharma

• Cephalon's Nuvigil Test Included "Vacation" in France
• UPDATED: Sanofi's Lantus Cancer Scare Triggered by Doc Backed by Amylin and Lilly
• Sanofi: 1,300 Jobs Lost; U.S. Staff Largely Unscathed
• Why J&J's $1.7B Win in Abbott Humira Case May be Garbage
• Pfizer's Foreign Viagra Ads: Mailman Jokes; Space Sperm and the Fountain of Youth
• Sanofi's Lantus Cancer Scare Shows How Enormous Power Lies With Few Experts
• The 10 Weirdest Drug Stories of the Month
• If Novartis Buys Elan's Tysabri and MS Drug, There Won't Be Much Elan Left
• Sanofi Eats Merck's Vaccine Business for Lunch; Hopes Pinned on "Gardasil for Boys"
• Pfizer's Off-Label Bextra Team Was Called "The Highlanders"
• More Pharma Insights